Reseach Article
Clinical Study of Neuroendoscopic Treatment of Subacute Subdural Hematoma (SSH)
Xuejian Wang, Xiangdong Li* and Zhifeng Wang
Department of Neurosurgery, First Affiliated Hospital of Soochow University, Soochow University, Soochow, Jiangsu, PR China
Department of Neurosurgery, First Affiliated Hospital of Soochow University, Soochow University, Soochow, Jiangsu, PR China
Received Date: July 02, 2020; Published Date: July 21, 2020
Abstract
Background: To investigate the methods of neuro-endoscopic treatment on subacute subdural hematoma (SSH), as well as the related surgical techniques and effects.
Methods: The clinical data of 14 patients with SSH who underwent neuroendoscopic treatment in our hospital from September 2018 to June 2019 were retrospectively analyzed. CT and MRI were performed before operation to confirm the diagnosis. 10 cases underwent general anesthesia, and 4 cases underwent local anesthesia. The hematoma was cleared under neuroendoscopy.
Results: All cases were successfully operated. The effective rate was 100%. At the time of discharge, 12 cases showed complete disappearance of hematoma, and 2 cases showed a small amount of remaining liquid and gas, as examined by CT scan. The muscle strength of hemiplegic limb significantly recovered after operation, and the patient’s self-care ability was obviously improved. No surgical complication occurred, and no recurrence happened in 3 months.
Conclusion: The application of neuro-endoscopy in treating subacute subdural hematoma (SSH) is clinically effective, with less trauma, good efficacy, and better safety. Therefore, this method should be widely applied in clinical practice.
Keywords: Subacute subdural hematoma; Neuro-endoscopy; Small bone window
Abbreviation: SSH: subacute Subdural Hematoma; CT: Computerized Tomography; MRI: Magnetic Resonance Imaging
-
Xuejian Wang, Xiangdong Li, Zhifeng Wang. Clinical Study of Neuroendoscopic Treatment of Subacute Subdural Hematoma (SSH). 8(3): 2020. ANN.MS.ID.000687.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.